Olympus to Acquire BioProtect for $270 Million to Expand Urology Portfolio and Address Prostate Cancer
Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding the company’s biodegradable Balloon Spacer system for prostate cancer radiation therapy to expand its urological technologies portfolio.
Meer lezen